ClinicalTrials.gov
ClinicalTrials.gov Menu

Effective Implementation of Interpersonal Psychotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03170908
Recruitment Status : Not yet recruiting
First Posted : May 31, 2017
Last Update Posted : January 10, 2018
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Scott P. Stuart, University of Iowa

Brief Summary:
The study is designed to observe the impact of improved measures of the fidelity on the community delivery of Interpersonal Psychotherapy. Pairs of therapist-patient dyads will be observed, first to develop and test brief measures of fidelity, and then to correlate those measures with symptomatic outcomes.

Condition or disease Intervention/treatment
Depressive Symptoms Behavioral: Interpersonal Psychotherapy

Detailed Description:
The study is designed to observe the impact of improved measures of the fidelity on the community delivery of Interpersonal Psychotherapy. In Phase I, 250 pairs of therapist-patient dyads will be observed as IPT Fidelity measures are developed and validated. In Phase II, 175 pairs of therapist-patient dyads will be observed to prospectively validate the IPT Fidelity measures with longitudinal outcomes on the PHQ-9.

Study Type : Observational
Estimated Enrollment : 425 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Pragmatic Strategies for Assessing and Enhancing High Fidelity Delivery of Interpersonal Psychotherapy (IPT) in Community Practice
Estimated Study Start Date : July 2018
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Phase I Patients
Patients with depression receiving community-based services will receive Interpersonal Psychotherapy
Behavioral: Interpersonal Psychotherapy
Interpersonal Psychotherapy (IPT) is an empirically-validated time-limited treatment for depression

Phase II Patients
Patients with depression receiving community-based services will receive Interpersonal Psychotherapy
Behavioral: Interpersonal Psychotherapy
Interpersonal Psychotherapy (IPT) is an empirically-validated time-limited treatment for depression




Primary Outcome Measures :
  1. PHQ-9 [ Time Frame: one year ]
    Patient Health Questionnaire-9



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients aged 18-99 seeking psychotherapy for depression in community-based agencies
Criteria

Inclusion Criteria:

  • age 18-99
  • diagnosis of depressive disorder
  • being treated with IPT in community settings

Exclusion Criteria:

- none


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03170908


Locations
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
Sponsors and Collaborators
Scott P. Stuart
National Institute of Mental Health (NIMH)

Responsible Party: Scott P. Stuart, Professor, Dept of Psychiatry, University of Iowa
ClinicalTrials.gov Identifier: NCT03170908     History of Changes
Other Study ID Numbers: 201705766
1R01MH112624 ( U.S. NIH Grant/Contract )
First Posted: May 31, 2017    Key Record Dates
Last Update Posted: January 10, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: we do not plan to share IPD

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Depression
Behavioral Symptoms